← Back
$OLMA All transactions

Olema Pharmaceuticals, Inc.

▼ SELL

$ Value

$601K

Shares

24,767

Price

$24

Filed

Mar 5

Insider

Name

Mitchell Shawnte

Title

CHIEF LEGAL OFFICER

CIK

0001749432

Roles

Officer

Transaction Details

Transaction Date

2026-03-04

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

233

Footnotes

The weighted average sale price for the transaction reported was $23.01, and the range of prices were between $22.89 and $23.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. | The weighted average sale price for the transaction reported was $24.25, and the range of prices were between $23.68 and $24.64. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. | The weighted average sale price for the transaction reported was $24.69, and the range of prices were between $24.68 and $24.70. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. | 25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Filing Info

Accession No.

0001749432-26-000004

Form Type

4

Issuer CIK

0001750284

Mitchell Shawnte's History

Date Ticker Type Value
2026-03-04 OLMA M $109K
2026-03-04 OLMA $601K
2026-03-04 OLMA $6K
2026-03-04 OLMA M $0
2026-03-03 OLMA M $66K
2026-03-03 OLMA $345K
2026-03-03 OLMA M $0
2026-02-02 OLMA A $0
2026-02-02 OLMA A $0

Other Insiders at OLMA (90d)

Insider Bought Sold Last
Mitchell Shawnte
CHIEF LEGAL OFFICER
$351K 2026-03-04
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
2026-02-02
Bohen Sean
PRESIDENT AND CEO
2026-02-02
Zojwalla Naseem
CHIEF MEDICAL OFFICER
2026-02-02
Austin Sasha Lu
VP of Finance and Controller
2026-02-02